India to export hydroxychloroquine on case-by-case basis

India will supply key drugs being tested as coronavirus cure to 'nations that have been badly affected' by the pandemic, the government said, hours after U.S President Donald Trump's stunning comments about 'retaliation' if Prime Minister Narendra Modi declined to ship the medicines.

India, which supplies more than a quarter of the world's generic drugs, had last month restricted exports of 26 pharmaceutical ingredients and the medicines made from them to ensure enough domestic stocks amid rising COVID-19 cases.

"In view of the humanitarian aspects of the pandemic, it has been decided that India would licence paracetamol and Hydroxychloroquine in appropriate quantities to all our neighbouring countries who are dependent on our capabilities. We will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic," Foreign Ministry spokesperson Anurag Srivastava said.

The Foreign Ministry said given the enormity of the COVID-19 pandemic, India has always maintained that the international community 'must display strong solidarity and co-operation'.